Protagonist Therapeutics Inc (PTGX)
Financial leverage ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 744,725 | 357,951 | 247,928 | 347,695 | 324,468 |
| Total stockholders’ equity | US$ in thousands | 675,295 | 336,677 | -536,755 | -409,362 | -283,811 |
| Financial leverage ratio | 1.10 | 1.06 | — | — | — |
December 31, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $744,725K ÷ $675,295K
= 1.10
The financial leverage ratio of Protagonist Therapeutics Inc remained at an undetermined level, indicated by dashes, for the years ending December 31, 2020, 2021, and 2022. However, starting from December 31, 2023, the financial leverage ratio was calculated at 1.06, and it increased slightly to 1.10 by the end of December 31, 2024. This signifies a moderate level of financial leverage for the company during these periods, indicating that a portion of the company's assets was funded through debt. The gradual increase in the ratio suggests a slightly higher reliance on debt financing over time, which could impact the company's financial risk and performance in the long run.
Peer comparison
Dec 31, 2024